Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > Some Thoughts in Summary
View:
Post by Boomskid on Dec 23, 2022 11:00am

Some Thoughts in Summary

I'm on the record about how this may have developed, or self-destructed, or was destroyed, whatever it was. I have posted my thoughts about motives and methods. I know that you are now swimming with sharks who are often motivated by exercising and proving their power and who often derive more satisfaction from destroying others than from winning for themselves.
 
I've posted a couple of times that the sharks may have motive to allow the share price to move up. With so much control in the hands of LT and The Placees, it's not possible to make predictions about their actions, actions that could include rollbacks, financings with LT friends who could gain 90% or greater ownership of Biodexa, taking Biodexa private, offloading most of the future value of the xB3 platform, all the way to running Biodexa in a manner that reflects the interests of all shareholders, however unlikely that may seem. I know they've been very careful and exhaustive in the setup, both to protect themselves legally and, yet, to get what they wanted, xB3. There are, in business, perfectly legal ways of destroying others.
 
On another note, over the years there have been times when digitel/prophetoffacts has posted stuff that I was almost certain came from Bioasis. We know that when Stockhouse is asked by a member to deactivate his account, as I just did with "JDavenport," that Stockhouse will not delete that member's posts. I didn't ask to have my posts deleted but Stockhouse wouldn't deactivate my account until I acknowledged to them that I understood that my posts would not be deleted, which was fine with me.
 
The other side of that, of course, is that if a member's account is deactivated and his posts removed by Stockhouse, it was likely for cause.
 
Knowing this suggests that prophetoffacts may have always been, and may remain, a gun for hire and that he does so without revealing it to readers. I've never been convinced that Stockhouse shuts a day trader down and deletes his posts for posting on the basis of his current trade, bashing when he's buying and pumping while he holds or is selling. I think they ban posters and delete their posts for more grievous, possibly illegal activities. You ought to consider these things when you read his posts. I don't think he's honest.
 
Some of you love bedlam, anger, and anarchy. You support those who reflect your own anger. You actively support the enemy of your enemy as a friend, and without consideration for your own welfare. Those attitudes and behaviours have manifested themselves on this forum for years. I have no doubt that for years it has played into the hands of those who wanted xB3 for themselves, and now they have it.
 
I think zwerp2000 offered as apt a benediction as any when he posted, "It's been over for a very, very long time."
 
I feared it, Rathjen knew it, and here we are.
 
You'll get a flavour of the plan very soon. You'll know whether Biodexa is taking on Denali, as it should. If they do, then everybody will make money. If this reaches a valuation similar to Denali's, of USD $3 billion, say, then with a billion shares outstanding, that would be almost $3.00 per share. Whether it's enough for LT and The Placees, or whether they want that big win for themselves remains to be seen.
 
Ok, off to Boomskid, but I'll be lurking. I'm curious.
 
Happy Holidays, or Merry Christmas, everybody.
 
JD Boomskid
 
 
Comment by narmac on Dec 23, 2022 11:27am
,,Can this investment get any more erroded than it has ,,,it must be assumed it certainly can,,,,,it cant even be considered an investment anymore,,,,,it has been a divestment now since the topping out at $2 back in Sept/16. A time which was strike while the iron is hot!!,,What ever failure happened at that time is a big question for all investors!!!,,,a shame but yet rerality! Now on life ...more  
Comment by KayakerBC on Dec 23, 2022 11:52am
Now on life support at .05 cents it becomes at the most a tax loss instrument now or down the road. Just as bad is MTP which again today has an untradeable spread of 0.70 x 0.79 and a price of 0.70. 1/25th of 0.70 is 2.8¢ US. And what are the odds that's the bottom?  Not good.
Comment by Boomskid on Dec 23, 2022 12:39pm
KayakerBC said about MTP at USD 2.8¢, "And what are the odds that's the bottom?  Not good." On the London Exchange, Midatech is essentially the same as on NASDAQ - 2.25 pence or CDN 3.7¢ On NASDAQ, as KBC states, the price is USD 2.8¢, which is CDN 3.8¢ BTI has to fall to less than 4¢ to be in line with the GB and USA share prices.  Using CDN 4& ...more  
Comment by prophetoffactz on Dec 23, 2022 12:45pm
",,Can this investment get any more erroded than it has ,,,it must be assumed it certainly can,,,,,it cant even be considered an investment anymore,,,," It's very important to draw a clear distinction between an investment and a speculation. It never was an 'investment'. It has always been a 'speculation'. It has never been in human trials let alone provided a proof ...more  
Comment by Boomskid on Dec 23, 2022 12:53pm
Biodexa wouldn't be funded for a year with $20 million, pof, and dilution with the exercising of the warrants would take place as well. Either another large financing or the selling of the xB3 platform will likely be needed to fund Biodexa. It's possible that $30 million or more up front could be paid for xB3-001, but it's totally unknown who will own xB3-001 at the time, and would ...more  
Comment by prophetoffactz on Dec 23, 2022 1:04pm
"Management estimates that the current cash balance (c £3.6m) will provide operational cash runway until Q123, which could extend to Q423 on successful conclusion of the fund-raise and acquisition." Edison Group Don't know if that is with the warrant exercise. Then add potential multi-product licensing deals on xB3 and Q-Sphera with J&J, and others potential deals ...more  
Comment by Boomskid on Dec 23, 2022 1:08pm
Yes, poof, everything will be swell. Biodexa can enter clinical trials with nothing but words. I would accuse you of dreaming, or just being wrong, poof, but you are malicious and we'll leave it at that. JD Boomskid
Comment by prophetoffactz on Dec 23, 2022 1:23pm
"Management estimates that the current cash balance (c £3.6m) will provide operational cash runway until Q123, which could extend to Q423 on successful conclusion of the fund-raise and acquisition." Edison Group It is very dumb to put a deal together like this and only provide it with a cash runway to Q4 2023. With one placee alone they raised US$10 million upfront ...more  
Comment by Boomskid on Dec 23, 2022 1:38pm
Lol, poof, Q123 starts in a week. With the financings you say that Midatech says that they would have enough money for another 2 to 3 quarters. Investing 101: Equity financings cause dilution. A rollback (likely) before a financing can pretty much wipe original investors out. You bought high, poof, and you can't pump it up to a profit (prophet?) unless Biodexa has a plan that is very ...more  
Comment by prophetoffactz on Dec 23, 2022 1:52pm
"Lol, poof, Q123 starts in a week. With the financings you say that Midatech says that they would have enough money for another 2 to 3 quarters." No. I'm saying that it is inconcievable that happened. There is high confidence significant cash is near. If there isn't they are in the same spot that led to this catastrophic dilution. Biodexa with Ladenberg Thalmann have defined a ...more  
Comment by Boomskid on Dec 23, 2022 2:05pm
Poof, the optics over the next Q or 2 could be swell. These are patient people. They took over 18 months to set this up.  I can't get over the question about where xB3 went in Rathjen's activities during that time. Why has xB3 virtually disappeared? They may want Biodexa to appear to have value without xB3, xB3-001 and all the other xB3s, named and unnamed. If you have another ...more  
Comment by prophetoffactz on Dec 23, 2022 2:40pm
"I can't get over the question about where xB3 went in Rathjen's activities during that time. Why has xB3 virtually disappeared?" It hasn't dissapeared. It is being positioned stronger than ever. A much stronger more viable company in Biodexa is being created to fully exploit it internally an externally. Biodexa has lead assets in the clinic which the market demands right ...more  
Comment by Boomskid on Dec 23, 2022 3:17pm
Yes, pof, maybe xB3 "is being positioned stronger than ever." But what were Rathjen's motives for hiding xB3 for the last year to eighteen months? Why isn't it being used to promote this deal and the share prices on the three exchanges? Everything means something, pof. xB3-001 Texas mice xB3-004 (xB3-IL1-Ra for AD, PD, MS, concussion, etc etc etc) progranulin Gaucher disease ...more  
Comment by prophetoffactz on Dec 23, 2022 3:45pm
. Rathjen publically set Lysosomal Storage Disorders, inflammation, and neurodegeneraion as BTI's strategic focus publically. This wasn't hidden. Herceptin was too costly. The Chiesi deal was signed. It wasn't hidden. This new strategic path takes time to develop. We are 2 1/2 years after the Chiesi signing and nothing yet; but it appears moving forward. A deal for Gaucher's ...more  
Comment by prophetoffactz on Dec 23, 2022 3:48pm
Rathjen also signed the J&J option on xB3. In a more normal biotech market the stock may have responded. The multi-product J&J option on xB3 wasn't hidden. It is also only an option. Let's see a full license.
Comment by Boomskid on Dec 23, 2022 4:18pm
Material Transfer Agreements with J&J and the others are secret, pof. They generate no revenue until they result in a deal being executed, and they have never helped the Bioasis share price. Don't tout them as reasons for celebration. Any of them that might turn into business deals with revenue are timed to happen for Biodexa, not for Bioasis. And the market is saying the deal and all ...more  
Comment by prophetoffactz on Dec 23, 2022 4:47pm
"And the market is saying the deal and all the little deals within it are collectively worth less than 4¢." That's what you think it's worth. BTI and Midatech shareholders actually got a ~15% fully diluted share position in Biodexa. If the deal and financing closes the deal and financial status of Biodexa will be de-risked. The financing could result in a US$20 million ...more  
Comment by unclepieman on Dec 23, 2022 5:59pm
Lol it's like 10 years ago all over again! Hahaha one "if" after another "if" is how many have lost hundreds of thousands, me included! Get lost and stop trying to take peoples hard earned money you scammers! 
Comment by emmitfitzhume on Dec 27, 2022 10:05am
I am a long time shareholder, participant in prior raises and private placements, have followed this board over the years but posted very infrequently. I tend to agree with JD and much of his thinking here. This proposed buyout of Biosis seems very disrespectful to current shareholders, and certainly not in line with prior guidance of being value accretive and non dilutive… The current fire ...more  
Comment by zwerp2000 on Dec 27, 2022 10:28am
Nice post but the answer is obvious and has been for years. There is no value to XB3. Several companies "test drove" the technology but decided not to do anything with it. The company probably thought they'd find a suitor at some point but that never materialized. Even Chiesi did nothing with the XB3. Now, with the company out of money and out of funds, had no other choice but to ...more  
Comment by G1945V on Dec 28, 2022 10:30am
zwerp, but at this price level of (CAN), 5 cents would you consider BTI a good entry point for newbies? G1945V
Comment by zwerp2000 on Dec 28, 2022 10:48am
No! It's time to move on. This company is cooked. It's been cooked for years. They had years to push their pipeline forward but never did it. Why? Also, if xb3 was truly so valuable, how could the company not be able to secure financing or a partnership deal that would land them a decent upfront payment? How is the recent deal the best they can do with a "valuable" technology ...more  
Comment by fuzzyjr on Dec 28, 2022 11:40am
If majority of people were in this at an average of .05 to a dime there would a lot less madness imo. as far as what the last two ceos think , who cares , they both accomplished absolutely nothing & led many to believe there was much more coming , complete failures imo - they belong in the same heap as Don mCnothing over at rv & zen - sure many over there would be much happier with a ...more  
Comment by prophetoffactz on Dec 27, 2022 11:22am
"The current fire sale for which Bioasis is being offered up for would lead a person to come to one of two logical conclusions, that XB3 does not work or that something more nefarious is afoot."  We are in the worst biotech bear market in history. It's been like a 1-in-100 year flood wiping out Biotech City. A 1-in-100 year pandemic requiring massive money printing to keep the ...more  
Comment by zwerp2000 on Dec 27, 2022 11:30am
More absurdity from "prophet". I see he really did not address your concerns. Instead he spews his typical fluff and nonsensicle rhetoric. A few years ago we were in a huge biotech bull market and this stock did absolutely nothing so that kind of invalidates his comments. 
Comment by fuzzyjr on Dec 27, 2022 1:53pm
 u summed up a yes vote below- we don't see another company/entity coming forward "yet" to counter this offer & haven't seen any one put forward a plan b of any kind to addres what it would take financially to clear up current debt , place yet another acting ceo & at what would be that exact/even rough cost/further dilution to existing shareholders trying to raise a ...more  
Comment by narmac on Dec 23, 2022 1:02pm
,.,.,I dont hold any interest in xB3 at this stage,,,,nor does anyone else out there,,,,,,it has created ZERO value being expressed in share price,,,,,,it is dead technology,,,,, unless a partner releaseses positive data down the road, and I dont fear that happening.  Management just never told their shareholders that!!,,,,As far as I can read between the lines xB3 will otherwise just fade ...more  
Comment by Itistoo on Dec 26, 2022 4:43pm
Keep buying then at these bargain prices then pof you moron. Anyone with half a brain knows this is dead. There may be some more money to be made off this stoxk before it delist, but it won't be retail shareholders 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities